Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results

NCT06438055 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Refractory Breast Cancer

Interventions

OTHER: Chemotherapy and targeted-therapy guided by organoid drug sensitivity test

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]